Lung Cancer Study Day Optimising Lung Cancer Treatments: Time to Breathe
Provided by Doctors Academy
About the course
verview
This multidisciplinary study day aims to explore redefined care for lung cancer patients. Attendees will explore updates regarding current genetic approaches to treatment, and the importance of support from all members of the team.
Keynote Speakers
Dr Colin Lindsay - Honorary Academic Consultant Medical Oncologist - The Christie NHS Foundation Trust
Mathew Carter - Scientific Officer, Manchester Cancer research Centre, The Christie NHS Foundation Trust
Topics covered
- Patient support
- Complimentary therapies
- Pain management
- Multidisciplinary approach
- Quality of life focus
Learning outcomes
The day aims to update the multi disciplinary team caring for lung cancer patients regarding current genetic approaches to treatment, and the importance of support from all members of the team. Attendees will develop their knowledge of new treatments and how to treat adverse events, The event aims to focus on improving patient outcomes with multiple lines of treatment.
Aim/objectives
The day aims to update the multi disciplinary team caring for lung cancer patients regarding current genetic approaches to treatment, and the importance of support from all members of the team. Attendees will develop their knowledge of new treatments and how to treat adverse events. The event will focus on improving patient outcomes with multiple lines of treatment, addressing ‘Living with and Beyond’ lung cancer – improving quality of life and managing patient concerns. This will be demonstrated in the final session of the day.
Intended audience
All members of the MDT. To include: Nurses, Allied Health Professionals, GPs, medical staff & clinical research teams.
Delivery
This teaching will be delivered through a varied programmed of speaker presentations and interactive discussion sessions.